Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

12.25
Delayed Data
As of Jan 19
 -0.40 / -3.16%
Today’s Change
4.20
Today|||52-Week Range
13.43
+0.08%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close12.65
Today’s open12.47
Day’s range11.91 - 12.60
Volume497,157
Average volume (3 months)334,163
Market cap$587.0M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-12.71%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+28.82%
P/E ratioNM
Price/Sales8.30
Price/Book11.08

Competitors

----
BEATBioTelemetry Inc+0.65+3.00%
NVCRNovocure Ltd+0.25+3.88%
----
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$39.4M
Annual profit (last year)-$42.2M
Net profit margin-107.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts


Search for Jobs